Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Tananbaum James B. Create: Alert

All | News | Filings
Date FiledTypeDescription
07/19/2023 4 Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.
Txns: Bought 523,450 shares @ $2.97, valued at $1.6M
Bought 176,550 shares @ $2.97, valued at $524.4k
05/10/2023 4 Tananbaum James B. (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 1,550,956 shares @ $2.8, valued at $4.3M
Bought 229,044 shares @ $2.8, valued at $641.3k
02/22/2023 4 Tananbaum James B. (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Acquired 1,100,000 shares @ $0
01/03/2023 4 Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.
Txns: Bought 250,000 shares @ $5, valued at $1.3M
Bought 250,000 shares @ $5, valued at $1.3M
12/05/2022 4 Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on PARDES BIOSCIENCES, INC.
Txns: Bought 637,420 shares @ $0.85, valued at $541.8k
06/15/2022 4 Tananbaum James B. (Director) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 20,250 options to buy @ $8.38, valued at $169.7k
06/13/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/30/2021 4/A Tananbaum James B. (10% Owner) has filed a Form 4 on PARDES BIOSCIENCES, INC.
Txns: Converted 4,941,250 shares @ $0
Converted 4,941,250 options to buy @ $0
12/28/2021 4 Tananbaum James B. (10% Owner) has filed a Form 4 on PARDES BIOSCIENCES, INC.
Txns: Granted 1,000,000 shares @ $10, valued at $10M
Converted 4,873,750 shares @ $0
Granted 7,759,072 shares @ $0
Converted 4,873,750 options to buy @ $0
Granted 75,000 options to buy @ $9.8, valued at $735k
12/23/2021 4 Tananbaum James B. (10% Owner) has filed a Form 4 on PARDES BIOSCIENCES, INC.
Txns: Bought 325,000 shares @ $10, valued at $3.3M
11/03/2021 4 Foresite Capital Management III, LLC (10% Owner) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Disposed of 1,954,904 shares @ $0
Acquired 8,276 shares @ $0
10/06/2021 4 Tananbaum James B. (10% Owner) has filed a Form 4 on Gemini Therapeutics, Inc. /DE
Txns: Granted 17,245 options to buy @ $3.8, valued at $65.5k
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/23/2021 4 FS Development Holdings II, LLC (10% Owner) has filed a Form 4 on FS Development Corp. II
Txns: Bought 602,500 shares @ $10, valued at $6M
02/16/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/10/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/09/2021 4 Tananbaum James B. (Director) has filed a Form 4 on Gemini Therapeutics, Inc. /DE
Txns: Granted 1,500,000 shares @ $10, valued at $15M
Converted 2,928,750 shares @ $0
Converted 2,928,750 options to buy @ $0
12/09/2020 4 Tananbaum James B. (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Converted 9,171,643 shares @ $0
Converted 500,001 shares @ $0
Converted 166,667 shares @ $0
Converted 6,347,893 preferred shares @ $0
Converted 298,465 preferred shares @ $0
Converted 99,488 preferred shares @ $0
Converted 2,666,002 preferred shares @ $0
Converted 55,922 preferred shares @ $0
Converted 18,641 preferred shares @ $0
Converted 157,222 preferred shares @ $0
Converted 145,128 preferred shares @ $0
12/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
10/19/2020 4 FS Development Holdings, LLC (10% Owner) has filed a Form 4 on FS Development Corp.
Txns: Bought 441,500 shares @ $10, valued at $4.4M
08/19/2020 3/A Tananbaum James B. (President & CEO) has filed a Form 3/A on FS Development Corp.
08/11/2020 3 Tananbaum James B. (President and CEO) has filed a Form 3 on FS Development Corp.
05/14/2020 4 Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns: Converted 1,930,198 shares @ $0
Sold 800,000 shares @ $80.13, valued at $64.1M
Sold 650,000 shares @ $80.13, valued at $52.1M
Converted 1,930,198 options to buy @ $0
05/08/2020 4 Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns: Converted 500,000 shares @ $0
Converted 1,500,000 shares @ $0
Converted 500,000 options to buy @ $0
Converted 1,500,000 options to buy @ $0
04/24/2020 4 Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns: Disposed of 700,000 shares @ $0
Acquired 178,584 shares @ $0
Disposed of 178,584 shares @ $0
Acquired 92,258 shares @ $0
Converted 1,000,000 shares @ $0
Converted 1,000,000 options to buy @ $0
04/15/2020 4 Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns: Disposed of 788,317 shares @ $0
Disposed of 433,725 shares @ $0
Acquired 201,115 shares @ $0
Disposed of 201,115 shares @ $0
Acquired 21,686 shares @ $0
Disposed of 21,686 shares @ $0
Acquired 109,849 shares @ $0
Converted 1,500,000 shares @ $0
Converted 1,500,000 options to buy @ $0
03/26/2020 4 Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns: Converted 2,170,619 shares @ $0
Converted 2,170,619 options to buy @ $0
03/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy